Skip to main content
. 2023 May 29;14:1182260. doi: 10.3389/fendo.2023.1182260

Table 1.

Participant demographic information.

Characteristic N (%)
Age (years), median (IQR) 16.2 (15.0-17.5)
Sex, male 16 (39%)
Race/ethnicity
 NH White 4 (9.8%)
 NH Black 33 (80.5%)
 Hispanic 4 (9.8%)
Public Insurance 31 (75.6%)
Parent Education (n=40)
 <HS 4 (10%)
 HS 25 (62.5%)
 >HS 11 (27.5%)
Parental Income<$50,000 (n=32) 26 (81.3%)
Duration of DM (years), median (IQR) 0.8 (0.4-2.6)
Diagnosis Age (years), mean (SD) 14.2 (2)
HbA1c percentage, median (IQR) 10.3 (7.3-12.5)
Body Mass Index (BMI – kg/m2), median (IQR) 37.3 (30.8-46.1)
On insulin 40 (97.6%)
 Basal/bolus regimen 34 (85%)
 Insulin dose (units/kg/day), median (IQR) 0.48 (0.33-0.8)
On Metformin 33 (80.5%)
 Metformin dose (mg/day), median (IQR) 2000 (1925-2000)
On Liraglutide 2 (4.9%)
 Needed compatible smart phone to use CGM 11 (26.8%)